Surface Oncology Reports Financial Results and Corporate Highlights for Fourth Quarter and Full Year 2019

NEXT STORY
Zynerba Pharmaceuticals Reports Fourth Quarter and Year End 2019 Financial Results and Operational Highlights
PREV STORY
Emergent BioSolutions Signs Development and Manufacturing Agreement With Novavax for Experimental Vaccine Candidate for Coronavirus Disease
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

SetPoint Medical to Present Results From The U.S. Pilot Study in Rheumatoid Arthritis Patients at European Congress of Rheumatology (EULAR) 2019

author_avatar
NASDAQ Market News

Roche’s IPATential150 study evaluating ipatasertib in combination with abiraterone and prednisone/prednisolone met one of its co-primary endpoints

author_avatar
NASDAQ Market News

CORRECTING and REPLACING: Athenex, Inc.

In a release issued earlier today by Athenex, Inc. (Nasdaq:ATNX), please note that the ...

author_avatar
NASDAQ Market News